Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-066382
Filing Date
2021-12-20
Accepted
2021-12-20 16:45:22
Documents
3
Period of Report
2021-12-20

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea152703-6k_scisparcltd.htm 6-K 11738
2 PRESS RELEASE TITLED: "SCISPARC ANNOUNCES APPROVAL OF UPLISTING TO THE NASDAQ CA ea152703ex99-1_scisparcltd.htm EX-99.1 6781
3 GRAPHIC ex99-1_001.jpg GRAPHIC 9218
  Complete submission text file 0001213900-21-066382.txt   32536
Mailing Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916
Business Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916 972-3-6103100
SciSparc Ltd. (Filer) CIK: 0001611746 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 211505788
SIC: 2834 Pharmaceutical Preparations